|
1
|
Rao AR, Motiwala HG and Karim OM: The
discovery of prostate-specific antigen. BJU Int. 101:5–10.
2008.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Stolzenburg JU, Graefen M, Kriegel C,
Michl U, Martin Morales A, Pommerville PJ, Manning M, Büttner H,
Henneges C and Schostak M: Effect of surgical approach on erectile
function recovery following bilateral nerve-sparing radical
prostatectomy: An evaluation utilising data from a randomised,
double-blind, double-dummy multicentre trial of tadalafil vs.
placebo. BJU Int. 116:241–251. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bratu OG, Diaconu CC, Mischianu DL,
Constantin T, Stanescu AM, Bungau SG, Ionita-Radu F and Marcu RD:
Therapeutic options in patients with biochemical recurrence after
radical prostatectomy (Review). Exp Ther Med. 18:5021–5025.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
European Association of Urology: Prostate
cancer guidelines. https://uroweb.org/guideline/prostate-cancer/#6.
Accessed Jan 20, 2020.
|
|
5
|
Vesa CM, Popa AR, Bungau S, Daina LG,
Buhas C, Judea-Pusta CT, Pasca B, Dimulescu IA and Zaha DC:
Exploration of insulin sensitivity, insulin resistance, early
insulin secretion andβ-cell function, and their relationship with
glycated hemoglobin level in normal weight patients with newly
diagnosed type 2 diabetes mellitus. Rev Chim. 70:4217–4223.
2019.
|
|
6
|
Popa AR, Bungau S, Vesa CM, Bondar AC,
Pantis C, Maghiar O, Dimulescu IA, Nistor-Cseppento DC and Rus M:
Evaluating the efficacy of the treatment with benfotiamine and
alpha-lipoic acid in distal symmetric painful diabetic
polyneuropathy. Rev Chim. 70:3108–3114. 2019.
|
|
7
|
Purza L, Abdel-Daim M, Belba A, Iovan C,
Bumbu A, Lazar L, Bungau S and Tit DM: Monitoring the effects of
various combination of specific drug therapies at different stages
of Alzheimer's dementia. Farmacia. 67:477–481. 2019.
|
|
8
|
Zaha DC, Bungau S, Aleya S, Tit DM, Vesa
CM, Popa AR, Pantis C, Maghiar OA, Bratu OG, Furau C, et al: What
antibiotics for what pathogens? The sensitivity spectrum of
isolated strains in an intensive care unit. Sci Total Environ.
687:118–127. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kadıoğlu A, Ortaç M, Dinçer M and Brock G:
Tadalafil therapy for erectile dysfunction following prostatectomy.
Ther Adv Urol. 7:146–151. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Barazani Y, Stahl PJ, Nagler HM and
Stember DS: Is there a rationale for penile rehabilitation
following radical prostatectomy? Am J Men Health. 9:35–43.
2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Abdel-Daim MM, El-Tawil OS, Bungau SG and
Atanasov AG: Applications of antioxidants in metabolic disorders
and degenerative siseases: Mechanistic approach. Oxid Med Cell
Longev. 2019(4179676)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Anwar Z, Sinha V, Mitra S, Mishra AK,
Ansari MH, Bharti A, Kumar V and Nigam AK: Erectile dysfunction: An
underestimated presentation in patients with diabetes mellitus.
Indian J Psychol Med. 39:600–604. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Montorsi P, Ravagnani PM, Galli S,
Rotatori F, Veglia F, Briganti A, Salonia A, Dehò F, Rigatti P,
Montorsi F, et al: Association between erectile dysfunction and
coronary artery disease. Role of coronary clinical presentation and
extent of coronary vessels involvement: The COBRA trial. Eur Heart
J. 27:2632–2639. 2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gandaglia G, Suardi N, Cucchiara V,
Bianchi M, Shariat SF, Roupret M, Salonia A, Montorsi F and
Briganti A: Penile rehabilitation after radical prostatectomy: Does
it work? Transl Androl Urol. 4:110–123. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Blecher G, Almekaty K, Kalejaiye O and
Minhas S: Does penile rehabilitation have a role in the treatment
of erectile dysfunction following radical prostatectomy? F1000Res.
6(1923)2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ben Khedher MR, Bouhajja H, Haj Ahmed S,
Abid M, Jamoussi K and Hammami M: Role of disturbed fatty acids
metabolism in the pathophysiology of diabetic erectile dysfunction.
Lipids Health Dis. 16(241)2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Mulhall JP: Penile rehabilitation
following radical prostatectomy. Curr Opin Urol. 18:613–620.
2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Mulhall JP, Slovick R, Hotaling J, Aviv N,
Valenzuela R, Waters WB and Flanigan RC: Erectile dysfunction after
radical prostatectomy: Hemodynamic profiles and their correlation
with the recovery of erectile function. J Urol. 167:1371–1375.
2002.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Nehra A, Goldstein I, Pabby A, Nugent M,
Huang YH, de las Morenas A, Krane RJ, Udelson D, Saenz de Tejada I
and Moreland RB: Mechanisms of venous leakage: A prospective
clinicopathological correlation of corporeal function and
structure. J Urol. 156:1320–1329. 1996.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Iacono F, Giannella R, Somma P, Manno G,
Fusco F and Mirone V: Histological alterations in cavernous tissue
after radical prostatectomy. J Urol. 173:1673–1676. 2005.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Clavell-Hernandez J and Wang R: Penile
rehabilitation following prostate cancer treatment: Review of
current literature. Asian J Androl. 17:916–922. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Montorsi F, Brock G, Lee J, Shapiro J, Van
Poppel H, Graefen M and Stief C: Effect of nightly versus on-demand
vardenafil on recovery of erectile function in men following
bilateral nerve-sparing radical prostatectomy. Eur Urol.
54:924–931. 2008.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Pavlovich CP, Levinson AW, Su LM, Mettee
LZ, Feng Z, Bivalacqua TJ and Trock BJ: Nightly vs on-demand
sildenafil for penile rehabilitation after minimally invasive
nerve-sparing radical prostatectomy: Results of a randomized
double-blind trial with placebo. BJU Int. 112:844–851.
2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kim DJ, Hawksworth DJ, Hurwitz LM, Cullen
J, Rosner IL, Lue TF and Dean RC: A prospective, randomized,
placebo-controlled trial of on-Demand vs. nightly sildenafil
citrate as assessed by Rigiscan and the international index of
erectile function. Andrology. 4:27–32. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Montorsi F, Brock G, Stolzenburg JU,
Mulhall J, Moncada I, Patel HR, Chevallier D, Krajka K, Henneges C,
Dickson R, et al: Effects of tadalafil treatment on erectile
function recovery following bilateral nerve-sparing radical
prostatectomy: A randomised placebo-controlled study (REACTT). Eur
Urol. 65:587–596. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kim S and Sung GT: Efficacy and safety of
tadalafil 5 mg once daily for the treatment of erectile dysfunction
after robot-assisted laparoscopic radical prostatectomy: A 2-year
follow-up. Sex Med. 6:108–114. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Moncada I, de Bethencourt FR, Lledó-García
E, Romero-Otero J, Turbi C, Büttner H, Henneges C and Martinez
Salamanca JI: Effects of tadalafil once daily or on demand versus
placebo on time to recovery of erectile function in patients after
bilateral nerve-sparing radical prostatectomy. World J Urol.
33:1031–1038. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Potdevin L, Ercolani M, Jeong J and Kim
IY: Functional and oncologic outcomes comparing interfascial and
intrafascial nerve sparing in robot-assisted laparoscopic radical
prostatectomies. J Endourol. 23:1479–1484. 2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Asimakopoulos AD, Pereira Fraga CT, Annino
F, Pasqualetti P, Calado AA and Mugnier C: Randomized comparison
between laparoscopic and robot-assisted nerve-sparing radical
prostatectomy. J Sex Med. 8:1503–1512. 2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Greco F, Hoda MR, Wagner S, Reichelt O,
Inferrera A, Magno C and Fornara P: Bilateral vs. unilateral
laparoscopic intrafascial nerve-sparing radical prostatectomy:
Evaluation of surgical and functional outcomes in 457 patients. BJU
Int. 108:583–587. 2011.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Montorsi F, Guazzoni G, Strambi LF, Da
Pozzo LF, Nava L, Barbieri L, Rigatti P, Pizzini G and Miani A:
Recovery of spontaneous erectile function after nerve-sparing
radical retropubic prostatectomy with and without early
intracavernous injections of alprostadil: Results of a prospective,
randomized trial. J Urol. 158:1408–1410. 1997.PubMed/NCBI
|
|
32
|
Bratu O, Spinu D, Oprea I, Popescu R,
Marcu D, Farcas C, Dinu M and Mischianu D: Complications of radical
retropubic prostatectomy - our experience. Rom J Mil Med.
118:23–25. 2015.
|
|
33
|
Marcu D, Spinu D, Mischianu D, Socea B,
Oprea I and Bratu O: Oncological follow-up after radical
prostatectomy. Rom J Mil Med. 120:39–42. 2017.
|
|
34
|
Popescu R, Bratu O, Spinu D, Marcu D,
Farcas C, Dinu M and Mischianu D: Neuroendocrine differentiation in
prostate cancer - a review. Rom J Mil Med. 118:16–19.
2015.PubMed/NCBI
|
|
35
|
Cherciu A, Spinu D, Sandru F, Marcu D,
Iorga L, Anghe R, Bratu O and Mischianu D: Erectile disfunction
after radical prostatectomy. Ann Acad Rom Scientists Ser Med.
1:29–34. 2020.
|
|
36
|
Yiou R, Bütow Z, Parisot J, Binhas M,
Lingombet O, Augustin D, de la Taille A and Audureau E: Is it worth
continuing sexual rehabilitation after radical prostatectomy with
intracavernous injection of alprostadil for more than 1 year? Sex
Med. 3:42–48. 2015.PubMed/NCBI View
Article : Google Scholar
|
